thiazolyl blue has been researched along with procainamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, JE; Rubin, RL; Uetrecht, JP | 1 |
| Bauder-Wüst, U; Eisenhut, M; Haberkorn, U; Mier, W; Mohammed, A; Schönsiegel, F; Wolf, M | 1 |
2 other study(ies) available for thiazolyl blue and procainamide
| Article | Year |
|---|---|
Cytotoxicity of oxidative metabolites of procainamide.
Topics: Ascorbic Acid; Blood Physiological Phenomena; Cell Line; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Humans; Hydroxylamine; Hydroxylamines; Lymphocyte Activation; NAD; Oxidation-Reduction; Procainamide; Tetrazolium Salts; Thiazoles | 1987 |
Alkylating benzamides with melanoma cytotoxicity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Cell Line, Tumor; Cell Survival; Chlorambucil; Coloring Agents; Disease Models, Animal; Drug Delivery Systems; Drug Design; Ethylamines; HeLa Cells; Humans; Melanoma; Melanoma, Experimental; Mice; Models, Chemical; Neoplasms, Experimental; NIH 3T3 Cells; Procainamide; Tetrazolium Salts; Thiazoles; Time Factors; Tissue Distribution | 2004 |